Diagnozė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 133,599 | 141,467 | 146,321 | 139,743 | 172,250 | 205,955 | 241,471 | 261,451 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 67,675 | 74,998 | 111,212 | 67,287 | 71,672 | 103,177 | 115,479 | 118,395 |
| Equity | 86,484 | 75,122 | 91,032 | 93,513 | 119,258 | 171,760 | 168,138 | 169,633 |
| Liabilities | 5,403 | 4,235 | 5,314 | 19,456 | 5,569 | 2,434 | 3,111 | 10,034 |
| Non-current assets | 748 | 35 | 35 | 47,847 | 32,659 | 73,492 | 55,831 | 45,523 |
| Current assets | 91,139 | 79,322 | 96,311 | 65,122 | 92,168 | 100,702 | 115,418 | 172,058 |
| Total assets | 91,887 | 79,357 | 96,346 | 112,969 | 124,827 | 174,194 | 171,249 | 217,581 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 22,672 | 32,581 | 37,440 |
| Social insurance contributions | - | - | - | - | - | 18,886 | 21,291 | 25,005 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -0.7% | +5.9% | +3.4% | -4.5% | +23.3% | +19.6% | +17.2% | +8.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 73.7% | 94.5% | 115.4% | 59.6% | 57.4% | 59.2% | 67.4% | 54.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 78.3% | 99.8% | 122.2% | 72.0% | 60.1% | 60.1% | 68.7% | 69.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 50.7% | 53.0% | 76.0% | 48.2% | 41.6% | 50.1% | 47.8% | 45.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 23,928 | 23,578 | 24,387 | 22,661 | 28,708 | 34,326 | 40,245 | 43,575 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Diagnozė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 397.97 |
| 2026-05-03 | 2026-05-04 | 2.62 |
| 2026-04-24 | 2026-04-29 | 2.62 |
| 2026-01-16 | 2026-01-19 | 2014.17 |
| 2022-05-17 | 2022-05-19 | 0.97 |
| 2022-01-18 | 2022-01-19 | 1464.61 |
Diagnozė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Diagnoze, UAB (code 148353363) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €261.5K and net profit of €118.4K, with a profit margin of 45.3%. Revenue increased by 8.3% year on year and by 26.9% over two years, showing a steady upward trend from €206.0K in 2023 to €241.5K in 2024 and €261.5K in 2025. Net profit also remained strong, rising from €103.2K in 2023 to €115.5K in 2024 and €118.4K in 2025, although the margin eased gradually from 50.1% to 47.8% and then to 45.3%. At the end of 2025, total assets stood at €217.6K, equity at €169.6K, and liabilities at €10.0K. The balance sheet indicates a high equity ratio of 78.0% and a low debt-to-equity ratio of 0.06. Return on equity was 69.8%, return on assets 54.4%, and asset turnover 1.20x. Revenue per employee was €43.6K, supporting profitability.